Actively Recruiting

Phase 1
Age: 10Years +
All Genders
NCT05682144

ISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS I

Led by Immusoft of CA, Inc. · Updated on 2026-03-30

11

Participants Needed

2

Research Sites

1103 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

A first-in-human study using ISP-001 in patients with Mucopolysaccharidosis Type I Hurler-Scheie and Scheie.

CONDITIONS

Official Title

ISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS I

Who Can Participate

Age: 10Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of Mucopolysaccharidosis type I Hurler-Scheie or Scheie syndrome.
  • Age 10 years or older at time of study registration.
  • Creatinine clearance greater than 60 ml/min/1.73m2.
  • Ejection fraction 40% or higher by echocardiogram.
  • Willingness to travel to the study site for follow-up evaluations.
  • Agreement to stay within 45-minute drive from the study site for at least 5 days after cell infusion.
Not Eligible

You will not qualify if you...

  • Known familial inherited cancer syndrome or suspected cases under genetic investigation.
  • History of B cell related cancer, EBV lymphoproliferative disease, or autoimmune disorders.
  • Evidence of active graft-versus-host disease.
  • Previous hematopoietic stem cell transplant.
  • Need for systemic immune suppression.
  • Need for continuous supplemental oxygen.
  • Any medical condition that may interfere with safety or efficacy assessment.
  • Unlikely to complete all required study visits or comply with study requirements, as judged by investigator.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

UCSF Benioff Children's Hospital Oakland

Oakland, California, United States, 94609

Actively Recruiting

2

University of Minnesota

Minneapolis, Minnesota, United States, 55455

Actively Recruiting

Loading map...

Research Team

J

Jake Wesley, PharmD, MS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

SEQUENTIAL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

ISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS I | DecenTrialz